All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Results from Phase 3 trials for non-infectious uveitis treatment ➤ FDA allows new gene therapy for Leber congenital amaurosis to begin clinical testing ➤ FDA approves OTC drop for redness ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
Jacques Daviel, MD, is credited with performing the first planned extracapsular cataract extraction, and recently, Christopher Leffler, MD, and colleagues added to the history surrounding this procedure. In an article published online ahead of print in JCRS, they announced previously unreported notices and details about Dr. Daviel’s first-in-human cataract extraction.
➤ Presbyopia-correcting eye drop receives FDA approval ➤ Four-year, first-in-human results for IOL-based drug delivery system ➤ FDA approves new treatment for thyroid eye disease ➤ New registry establishes baseline for interventional glaucoma procedures in the U.S. ➤ Phase 3 study for DME does not meet primary endpoint, triggering strategic decisions ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ Phase 4 results for iDose TR ➤ Phase 3 extension study showcases positive results with epithelium-on crosslinking ➤ 6-month results from bio-reinforced canaloplasty procedure for glaucoma ➤ Dosing update in Phase 1 study evaluating mRNA treatment of optic atrophy ➤ Enrollment complete in Phase 2a study for geographic atrophy ➤ IND amendment submitted to FDA to expand indication for product candidate ➤ Complimentary access to video journal ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
In cataract surgery, surgeons should always be prepared for potential challenges or complications, but some are more common and well documented than others. Two ophthalmologists discussed an uncommon cataract complication that they think is important to call attention to and what others should know when dealing with these.
There is currently not an FDA-approved intracameral antibiotic in the U.S., but there are FDA-approved options for dropless pain and inflammation treatment after cataract surgery, and some surgeons, including three who spoke with EyeWorld, have chosen to employ a dropless approach off-label, based on available safety and efficacy data.
➤ FDA approves ‘world’s first’ spiral IOL platform ➤ Company to submit formal appeal after FDA’s denial of dry eye disease NDA ➤ FDA to hold Advisory Committee meeting for low-dose atropine treatment for myopia ➤ Positive results in Phase 3 trial for AMD treatment ➤ Phase 3 trial investigating DME treatment begins ➤ ASCRS news and events ➤ EyeWorld article of the week
There are several all-in-one phacovitrectomy machines on the market that seek to streamline workflows, reduce equipment footprint, and improve efficiency. The decision to invest in a combined system depends on case mix, staffing patterns, and how often vitreous management is needed in the cataract OR. Three physicians weighed in on the topic.
➤ Enrollment complete in pivotal trial for first-in-class regenerative cell therapy ➤ First patients dosed in Phase 3 trial for TED treatment ➤ 6-month results with virtual aperture IOL ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
The article recaps a symposium at the ASCRS Annual Meeting hosted by the combined societies of ASCRS, ESCRS, APACRS focusing on topics in AI, robotics, and surgical simulation, with representatives from all three societies presenting.
Get the latest ophthalmology news delivered to your inbox every Friday.